Intervention Review
Haloperidol versus placebo for schizophrenia
Editorial Group: Cochrane Schizophrenia Group
Published Online: 12 MAY 2010
Assessed as up-to-date: 22 AUG 2006
DOI: 10.1002/14651858.CD003082.pub2
Copyright © 2011 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Database Title
Additional Information
How to Cite
Irving CB, Adams CE, Lawrie S. Haloperidol versus placebo for schizophrenia. Cochrane Database of Systematic Reviews 2006, Issue 4. Art. No.: CD003082. DOI: 10.1002/14651858.CD003082.pub2.
Publication History
- Publication Status: Edited (no change to conclusions)
- Published Online: 12 MAY 2010
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- Login via Athens http://onlinelibrary.wiley.com/athens or other institutional login options http://onlinelibrary.wiley.com/login-options .
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- If you already have a Wiley Online Library or Wiley InterScience user account: login above and proceed to purchase the article.
- New Users: Please register, then proceed to purchase the article.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!